Publications by authors named "Tim W Failes"

Claim this Profile
F
FDA-approved disulfiram as a novel treatment for aggressive leukemia.
Mawar Karsa, Lin Xiao, Emma Ronca, Angelika Bongers, Dayna Spurling, Tim W Failes

J Mol Med (Berl)· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination drug screen targeting glioblastoma core vulnerabilities reveals pharmacological synergisms.
Jérémy Ariey-Bonnet, Raphael Berges, Marie-Pierre Montero, Baptiste Mouysset, Patricia Piris, Tim W Failes

EBioMedicine· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro and in vivo drug screens of tumor cells identify novel therapies for high-risk child cancer.
Loretta M S Lau, Chelsea Mayoh, Jinhan Xie, Paulette Barahona, Karen L MacKenzie, Tim W Failes

EMBO Mol Med· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-Content Imaging of Unbiased Chemical Perturbations Reveals that the Phenotypic Plasticity of the Actin Cytoskeleton Is Constrained.
Nicole S Bryce, Tim W Failes, Justine R Stehn, Karen Baker, Stefan Zahler

Cell Syst· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel small molecule that kills a subset of MLL-rearranged leukemia cells by inducing mitochondrial dysfunction.
Klaartje Somers, Victoria W Wen, Shiloh M C Middlemiss, Brenna Osborne, Helen Forgham, Tim W Failes

Oncogene· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of new MRP4 inhibitors from a library of FDA approved drugs using a high-throughput bioluminescence screen.
Leanna Cheung, Denise M T Yu, Zillan Neiron, Tim W Failes, Greg M Arndt

Biochem Pharmacol· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis